Filtered By:
Infectious Disease: Herpes
This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 364 results found since Jan 2013.
Acupuncture, Shingles, and Allergen Immunotherapy
Conclusions: Acupuncture is a minor trauma that can predispose a patient to reactivation of VZV and shingles in the setting of immune activation with allergen immunotherapy.PMID:34976278 | PMC:PMC8716517 | DOI:10.1089/acu.2020.1521
Source: Acupuncture in Medicine - January 3, 2022 Category: Complementary Medicine Authors: David McMahon Sushma Kadiyala Irene M Estores Source Type: research
A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine
Am J Epidemiol. 2022 Feb 12:kwac030. doi: 10.1093/aje/kwac030. Online ahead of print.ABSTRACTThe recombinant herpes zoster vaccine (RZV), approved as a 2-dose series in the U.S. in October 2017, has proven highly effective and generally safe. However, a small risk of Guillain-Barré syndrome (GBS) after vaccination was identified post-approval, and questions remain about other possible adverse events. This data-mining study assessed RZV safety in the U.S. using the self-controlled tree-temporal scan statistic, scanning data on thousands of diagnoses recorded during follow-up to detect any statistically unusual temporal clu...
Source: Herpes - February 13, 2022 Category: Infectious Diseases Authors: W Katherine Yih Martin Kulldorff Inna Dashevsky Judith C Maro Source Type: research
Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections
CONCLUSION: Our data point to long-term abnormalities in the S1P signaling system as a biomarker for previous disseminated viral diseases and a potential treatment target in recurring infections.PMID:35304160 | DOI:10.1016/j.jaci.2022.02.027
Source: Herpes - March 19, 2022 Category: Infectious Diseases Authors: Evgeny Berdyshev Elena Goleva Irina Bronova Anna S Bronoff Joanne E Streib Kathryn A Vang Brittany N Richers Patricia Taylor Lisa Beck Miguel Villarreal Keli Johnson Gloria David Mark K Slifka Jon Hanifin Donald Ym Leung Source Type: research
Dupilumab-induced peripheral neuropathy in a patient with severe asthma
The anti –interleukin (IL)-4 receptor, an antibody dupilumab is used in the treatment of severe asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyps. Common adverse events reportedly include injection site reactions, conjunctivitis, headache, and oral herpes. Dr Lee et al1 provided the f irst reported case of very severe chronic inflammatory demyelinating polyradiculoneuropathy that developed 1.5 years after the initiation of dupilumab treatment for atopic dermatitis. Similarly, we have encountered a case of peripheral neuropathy in a patient with severe asthma being treated with du pilumab and wish to...
Source: Annals of Allergy, Asthma and Immunology - April 28, 2022 Category: Allergy & Immunology Authors: Mayuka Yamane, Hiroshi Ohnishi, Kimiko Tsuji, Kazuki Anabuki, Akihito Yokoyama Tags: Correspondence Source Type: research
Treatment with Intravenous Acyclovir Desensitization for Severe Acyclovir Allergy: A Case of Herpes Encephalitis
Mikrobiyol Bul. 2022 Apr;56(2):371-376. doi: 10.5578/mb.20229816.ABSTRACTHerpes simplex virus (HSV) is a sporadic viral encephalitis agent that causes high mortality and morbidity, accompanied by neurological dysfunction findings. Acyclovir is the only antiviral treatment option that should be initiated in all patients with suspected encephalitis as soon as possible. Acyclovir is rarely possible to cause allergic reactions. It may occur in a wide range from generalized cutaneous rash to Stevens-Johnson syndrome. A case of HSV-1 encephalitis who had no treatment option other than intravenous acyclovir and was successfully t...
Source: Herpes - April 28, 2022 Category: Infectious Diseases Authors: Tu ğba Arslan Gülen G üzin Özden Tuba Turan ç Source Type: research
